Marketing Pharmaceuticals 2016

Discuss the complexity of marketing and how to promote pharmaceuticals, biologics, and medical devices in an effective yet compliant manner in an evolving environment.

戻る Agenda

Session 8: Compliance Update Panel

Session Chair(s)

Scott Liebman

Partner

Loeb & Loeb, LLP, United States

From drug pricing to First Amendment questions and completion of Corporate Integrity Agreements, companies are facing new and challenging compliance issues. This panel will explore these new trends and offer insight on how to navigate the uncertainty.

Speaker(s)

Panelists

Joe Zimmerman

Actavis & Forest, United States

Former Senior Vice President, Chief Compliance Officer

Emily Wright, JD

Pfizer, United States

Senior Corporate Counsel

Howard L. Dorfman, JD

H. L. Dorfman Pharmaceutical Consulting, United States

Founder